From Grand View Research:

Atrial Fibrillation Market Will Be Worth $16.17 Billion By 2020: New Report By Grand View Research, Inc.

“The global market for atrial fibrillation procedures and products is expected to reach USD 16.17 billion by 2020 growing at a CAGR of 13.2%, according to a new study by Grand View Research, Inc. Growing incidences of atrial fibrillation, strokes and brain damage due to blood clots coupled with a growing global base of geriatric population is expected to be a key driver for this market. Some of the other drivers of this market include the introduction of technological advancements in the fields of radiofrequency and microwave catheter ablation, growing demand for minimally invasive procedures and … Relatively low prices associated with these products and the use of anti-coagulants as an add-on therapy to non-pharmacological procedures, are some of the drivers of this segment.”

The figure shows hospitalization rates by county in the Unites States over a 5 year period for ages 65 and older. Any area on the map shown in red means there is a rate of 5 to 14% hospitalization due to AFib. There are 40 million people over 65 in the US. During any given 5 year period, 10% of those individuals would result in 4 million patients being hospitalized due to AFib.